연구동향 분석

Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer

조진구 김종민 Dansaem Lim Yeojin Do Byung Su Kwon Woochul Chang Myeong-Sok Lee 2020년

논문상세정보
인용/피인용
' Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Angiogenesis
  • Ovarian cancer
  • Tumor vascularization
  • Vasculogenic mimicry
  • therapeutic target
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
185 0

0.0%

' Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer' 의 참고문헌

  • cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer
    Tang J [2016]
  • XIAP-associated factor 1(XAF1)suppresses angiogenesis in mouse endothelial cells
    Qiao L [2008]
  • Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Calpha in epithelial ovarian cancer
    Qi H [2014]
  • Vasculogenic mimicry : current status and future prospects
    Zhang S [2007]
  • Vascular endothelial growth factor-dependent and-independent regulation of angiogenesis
  • Vascular endothelial growth factor improves the therapeutic effects of cyclodextrin in Niemann-Pick type C mice
    정민석 [2019]
  • Vascular channel formation by human melanoma cells in vivo and in vitro : vasculogenic mimicry
    Maniotis AJ [1999]
  • Vascular Mimicry : Concepts and Implications for Anti-Angiogenic Therapy
  • VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro
    Mei J [2008]
  • VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer
    Chen Y [2018]
  • Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer
    Zhang D [2014]
  • Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma
    Zhu LM [2014]
  • The role of wnt signaling in physiological and pathological angiogenesis
    Dejana E [2010]
  • The role of the plasminogen activation system in angiogenesis and metastasis
    Rabbani SA [2001]
  • The role of microRNAs in ovarian cancer
    Kinose Y [2014]
  • The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer
    Sun Q [2014]
  • The quagmire of hCG and hCG testing in gynecologic oncology
    Muller CY [2009]
  • The involvement of apoptosis in melanoma vasculogenic mimicry
  • The great escape; the hallmarks of resistance to antiangiogenic therapy
  • The clinical significance of tumor cell-lined vasculature in ovarian carcinoma : implications for anti-vasculogenic therapy
    Sood AK [2002]
  • The Functions of MicroRNA-200 Family in Ovarian Cancer : Beyond Epithelial-Mesenchymal Transition
    Choi PW [2017]
  • Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer(AGO-OVAR 12) : a randomised, double-blind, placebo-controlled phase 3trial
    du Bois A [2016]
  • Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis
    Xu Y [2012]
  • Role of hCG in vasculogenic mimicry in OVCAR-3 ovarian cancer cell line
    Su M [2011]
  • Role of angiogenesis in tumor growth and metastasis
    Folkman J [2002]
  • Role of Xlinked inhibitor of apoptosisassociated factor1 in vasculogenic mimicry in ovarian cancer
    Wang Y [2017]
  • Regulation of IL-6 signaling by miR-125a and let-7e in endothelial cells controls vasculogenic mimicry formation of breast cancer cells
    박영숙 [2019]
  • Real World Experiences : Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
    Hughes G [2016]
  • Progressionfree survival by local investigator versus independent central review : comparative analysis of the AGO-OVAR16Trial
    Floquet A [2015]
  • Profile of nintedanib in the treatment of solid tumors : the evidence to date
    Awasthi N [2015]
  • Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo
    Su M [2008]
  • Peroxisome proliferator-activated receptor gamma ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway
    Qin L [2014]
  • Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer(MITO 11) : a randomised, open-label, phase 2trial
    Pignata S [2015]
  • Pazopanib in the treatment of soft tissue sarcoma
    Schoffski P [2012]
  • Pazopanib for the treatment of metastatic renal cell carcinoma
    Pick AM [2012]
  • Ovarian cancer
    Hennessy BT [2009]
  • New and Novel Therapies for Gynecologic Cancers
  • Molecular-targeted therapies for ovarian cancer : prospects for the future
    Sudo T [2012]
  • Molecular mechanisms and clinical applications of angiogenesis
    Carmeliet P [2011]
  • Molecular determinants of ovarian cancer plasticity
    Sood AK [2001]
  • Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry
    Zhang X [2019]
  • Mig-7 expression and vasculogenic mimicry in malignant ovarian tumors
  • MicroRNAs as critical regulators of the endothelial to mesenchymal transition in vascular biology
    김종민 [2018]
  • MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression
    Liu W [2017]
  • MicroRNA controls of cellular senescence
    서나영 [2018]
  • MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
    Lanqin Cao [2018]
  • Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis
    Sestito R [2016]
  • Limitations of Anti-Angiogenic Treatment of Tumors
    Ribatti D [2019]
  • L19-IL2Immunocytokine in Combination with the Anti-Syndecan-146F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model
    Orecchia P [2019]
  • Initial toxicity assessment of ICON6 : a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer
    Raja FA [2011]
  • Incorporation of pazopanib in maintenance therapy of ovarian cancer
    du Bois A [2014]
  • Immunomodulatory Activity of VEGF in Cancer
  • Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis : Applications and Therapies
    Zimna A [2015]
  • Hypoxia promotes vasculogenic mimicry formation by inducing epithelialmesenchymal transition in ovarian carcinoma
    Du J [2014]
  • Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma
    Sun B [2007]
  • HypoxamiRs Profiling Identify miR-745 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells
  • Hippo-YAP/TAZ signaling in angiogenesis
    박정애 [2018]
  • HIF1α promotes prostate cancer progression by increasing ATG5 expression
    Kaiyuan Yu [2019]
  • HCG in the regulation of placental angiogenesis. Results of an in vitro study
    Herr F [2007]
  • Functional significance of VEGF-a in human ovarian carcinoma : role in vasculogenic mimicry
    Wang JY [2008]
  • Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma
    Boocock CA [1995]
  • Expression and functional significance of VE-cadherin in aggressive human melanoma cells : role in vasculogenic mimicry
    Hendrix MJ [2001]
  • Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma
    Yu L [2017]
  • Epidemiology of epithelial ovarian cancer
    Webb PM [2017]
  • Endothelial miR-26a regulates VEGF-Nogo-B receptor-mediated angiogenesis
    조하늘 [2017]
  • Emerging role of RUNX3 in the regulation of tumor microenvironment
  • Effects of HCG on human epithelial ovarian cancer vasculogenic mimicry formation in vivo
    Gao S [2016]
  • Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells
    Cong R [2009]
  • Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives
  • Dishevelling Wnt and Hippo
    김남희 [2018]
  • Cediranib in patients with relapsed platinum-sensitive ovarian cancer(ICON6) : a randomised, double-blind, placebo-controlled phase 3 trial
  • Cancer stem cell metabolism: target for cancer therapy
    채영찬 [2018]
  • Cancer statistics, 2019
    Siegel RL [2019]
  • Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis
    Cheng N [2002]
  • Association of Vasculogenic Mimicry Formation and CD133 Expression with Poor Prognosis in Ovarian Cancer
    Liang J [2016]
  • Antiangiogenic therapies in ovarian cancer
  • Antiangiogenic agents in ovarian cancer : past, present, and future
    Monk BJ [2016]
  • Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer(TRINOVA-1) : a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
    Monk BJ [2014]
  • Angiogenesis in life, disease and medicine
    Carmeliet P [2005]
  • Angiogenesis and cancer stem cells : New perspectives on therapy of ovarian cancer
    Markowska A [2017]
  • Advances in ovarian cancer therapy
    Cortez AJ [2018]
  • AZD2171 : a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer
    Wedge SR [2005]
  • A new perspective of vasculogenic mimicry : EMT and cancer stem cells(Review)
    Fan YL [2013]